HMG-CoA Reductase Inhibitor [EPC]

359510 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

#	Side effect	Count
0	FATIGUE	20035
1	NAUSEA	18546
2	DRUG INEFFECTIVE	18227
3	DYSPNOEA	17676
4	DIARRHOEA	16852
5	DIZZINESS	15401
6	PAIN	13711
7	ASTHENIA	13123
8	HEADACHE	12672
9	FALL	12642

See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	CARDIOSPASM	262	0.6805
1	PALMOPLANTAR KERATODERMA	254	0.4903
2	IMMUNE-MEDIATED NECROTISING MYOPATHY	251	0.4580
3	IMMUNE-MEDIATED MYOSITIS	396	0.3426
4	CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER	267	0.2654
5	MYOPATHY	1816	0.2556
6	HYPERPARATHYROIDISM SECONDARY	578	0.2482
7	NEPHROGENIC ANAEMIA	1025	0.2335
8	RHABDOMYOLYSIS	7473	0.2187
9	ATRIAL TACHYCARDIA	357	0.2076

See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]